Načítá se...
Unilateral axillary Adenopathy in the setting of COVID-19 vaccine
With the recent U.S. Food and Drug Administration (FDA)-approval and rollout of the Pfizer-BioNTech and Moderna COVID-19 vaccines, it is important for radiologists to consider recent COVID-19 vaccination history as a possible differential diagnosis for patients with unilateral axillary adenopathy. H...
Uloženo v:
| Vydáno v: | Clin Imaging |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Published by Elsevier Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7817408/ https://ncbi.nlm.nih.gov/pubmed/33486146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinimag.2021.01.016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|